{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:02:10Z","timestamp":1778997730366,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["102378\/Z\/13"],"award-info":[{"award-number":["102378\/Z\/13"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US department of Veterans Affairs","doi-asserted-by":"crossref","award":["I01BX003755"],"award-info":[{"award-number":["I01BX003755"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"US department of Veterans Affairs","doi-asserted-by":"crossref","award":["I01BX002619"],"award-info":[{"award-number":["I01BX002619"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC Clinical Research Capabilities and Technologies Initiative","award":["MR\/M009114\/1"],"award-info":[{"award-number":["MR\/M009114\/1"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.nbd.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T18:16:19Z","timestamp":1529691379000},"page":"40-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["\u03b1-Methyl-\u03b1-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-3001","authenticated-orcid":false,"given":"Shi Quan","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew G.","family":"Pontifex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie M.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra","family":"Pidathala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-7634","authenticated-orcid":false,"given":"Brian C.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff W.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil G.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Burgoyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-1289","authenticated-orcid":false,"given":"Alan","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.06.013_bb0005","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.phymed.2010.03.008","article-title":"Epigallocatechin gallate inhibits beta amyloid oligomerization in Caenorhabditis elegans and affects the daf-2\/insulin-like signaling pathway","volume":"17","author":"Abbas","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nbd.2018.06.013_bb0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature09873","article-title":"Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan","volume":"472","author":"Alavez","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.06.013_bb0015","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1016\/j.bmcl.2010.10.068","article-title":"Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate","volume":"20","author":"Alelyunas","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2018.06.013_bb0020","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1038\/ncomms12408","article-title":"Projected increase in amyotrophic lateral sclerosis from 2015 to 2040","volume":"7","author":"Arthur","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2018.06.013_bb0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exger.2009.02.010","article-title":"Reserpine ameliorates Abeta toxicity in the Alzheimer's disease model in Caenorhabditis elegans","volume":"44","author":"Arya","year":"2009","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.nbd.2018.06.013_bb0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/ci00014a001","article-title":"Substructure searching methods: old and new","volume":"33","author":"Barnard","year":"1993","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.nbd.2018.06.013_bb0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.013_bb0040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.33.4.414","article-title":"Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions","volume":"33","author":"Browne","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.06.013_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nchembio.380","article-title":"A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans","volume":"6","author":"Burns","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2018.06.013_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1528-1157.1963.tb05209.x","article-title":"Anticonvulsant activity and toxicity of phensuximide, methsuximide and ethosuximide","volume":"4","author":"Chen","year":"1963","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2018.06.013_bb0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13065-015-0143-y","article-title":"Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases","volume":"9","author":"Chen","year":"2015","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.nbd.2018.06.013_bb0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-015-0046-3","article-title":"Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16\/FOXO target gene expression","volume":"10","author":"Chen","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.06.013_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000230","article-title":"The anticonvulsant ethosuximide disrupts sensory function to extend C. elegans lifespan","volume":"4","author":"Collins","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2018.06.013_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0304-3940(89)90376-5","article-title":"Specific petit mal anticonvulsants reduce calcium currents in thalamic neurons","volume":"98","author":"Coulter","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2018.06.013_bb0075","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ana.410250610","article-title":"Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons","volume":"25","author":"Coulter","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.06.013_bb0080","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1476-5381.1990.tb14095.x","article-title":"Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction","volume":"100","author":"Coulter","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2018.06.013_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-5347(24)07318-X","article-title":"Urinary metabolites of N-methyl-alpha-methyl-alpha-phenysuccinimide (methsuximide) in the dog","volume":"2","author":"Dudley","year":"1974","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.nbd.2018.06.013_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.1105299","article-title":"Anticonvulsant medications extend worm life-span","volume":"307","author":"Evason","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.06.013_bb0095","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/s41598-017-04256-w","article-title":"The stress response factor daf-16\/FOXO is required for multiple compound families to prolong the function of neurons with Huntington's disease","volume":"7","author":"Farina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2018.06.013_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-3565(25)21439-2","article-title":"Excitable channel currents and gating times in the presence of anticonvulsants ethosuximide and valproate","volume":"230","author":"Fohlmeister","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2018.06.013_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Frank-Cannon","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.06.013_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.21344","article-title":"TDP-43 A315T mutation in familial motor neuron disease","volume":"63","author":"Gitcho","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.06.013_bb0115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/mol.60.5.1121","article-title":"Block of cloned human T-type calcium channels by succinimide antiepileptic drugs","volume":"60","author":"Gomora","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2018.06.013_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1527-3458.2007.00009.x","article-title":"Ethosuximide: from bench to bedside","volume":"13","author":"Goren","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.nbd.2018.06.013_bb0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2202-6-54","article-title":"Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans","volume":"6","author":"Gutierrez-Zepeda","year":"2005","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2018.06.013_bb0130","doi-asserted-by":"crossref","first-page":"56147","DOI":"10.18632\/oncotarget.11269","article-title":"OASIS 2: online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research","volume":"7","author":"Han","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.nbd.2018.06.013_bb0135","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1242\/dev.00330","article-title":"Cyclic GMP-dependent protein kinase EGL-4 controls body size and lifespan in C elegans","volume":"130","author":"Hirose","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.nbd.2018.06.013_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1386207024607338","article-title":"Grouping of coefficients for the calculation of inter-molecular similarity and dissimilarity using 2D fragment bit-strings","volume":"5","author":"Holliday","year":"2002","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.nbd.2018.06.013_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1059-1311(96)80062-8","article-title":"Methsuximide therapy of juvenile myoclonic epilepsy","volume":"5","author":"Hurst","year":"1996","journal-title":"Seizure"},{"key":"10.1016\/j.nbd.2018.06.013_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2014a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.nbd.2018.06.013_bb0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11064-011-0580-5","article-title":"Effect of phenolic compounds against Abeta aggregation and Abeta-induced toxicity in transgenic C. elegans","volume":"37","author":"Jagota","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2018.06.013_bb0160","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1523\/JNEUROSCI.19-02-00539.1999","article-title":"The Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase and is required for synaptic transmission but not synaptic development","volume":"19","author":"Jin","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.013_bb0165","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1093\/hmg\/ddu316","article-title":"Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol","volume":"23","author":"Kashyap","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.06.013_bb0170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuropharm.2010.04.008","article-title":"Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans","volume":"59","author":"Keowkase","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2018.06.013_bb0175","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1081\/SCC-100104405","article-title":"Synthesis of exocyclic enamides via stereocontrolled allylic isomerization and 1,3-transposition","volume":"31","author":"Khan","year":"2001","journal-title":"Synth. Commun."},{"key":"10.1016\/j.nbd.2018.06.013_bb0180","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/hmg\/ddm143","article-title":"SUT-1 enables tau-induced neurotoxicity in C-elegans","volume":"16","author":"Kraemer","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.06.013_bb0185","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1073\/pnas.1533448100","article-title":"Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy","volume":"100","author":"Kraemer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.06.013_bb0190","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0028-3908(99)00202-6","article-title":"Regulation of the calcium channel alpha(1G) subunit by divalent cations and organic blockers","volume":"39","author":"Lacinova","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2018.06.013_bb0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.expneurol.2013.09.024","article-title":"Modeling neurodegenerative diseases in Caenorhabditis elegans","volume":"250","author":"Li","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.06.013_bb0200","doi-asserted-by":"crossref","first-page":"16208","DOI":"10.1523\/JNEUROSCI.2911-10.2010","article-title":"Phosphorylation promotes neurotoxicity in a C. Elegans model of TDP-43 proteinopathy","volume":"30","author":"Liachko","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.013_bb0205","doi-asserted-by":"crossref","first-page":"16208","DOI":"10.1523\/JNEUROSCI.2911-10.2010","article-title":"Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy","volume":"30","author":"Liachko","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.013_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027762","article-title":"FDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on Cbp and protect against proteotoxicity","volume":"6","author":"Lublin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.06.013_bb0215","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.biopsych.2012.08.027","article-title":"Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity","volume":"73","author":"Mccormick","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.06.013_bb0220","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1073\/pnas.0900191106","article-title":"Identifying the proteins to which small-molecule probes and drugs bind in cells","volume":"106","author":"Ong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.06.013_bb0225","article-title":"Basic Caenorhabditis elegans methods: synchronization and observation","volume":"4019","author":"Porta-De-La-Riva","year":"2012","journal-title":"J. Visualized Exp."},{"key":"10.1016\/j.nbd.2018.06.013_bb0230","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1212\/WNL.29.11.1509","article-title":"Plasma concentrations of phensuximide, methsuximide, and their metabolites in relation to clinical efficacy","volume":"29","author":"Porter","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.06.013_bb0235","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1359-6446(02)02411-X","article-title":"Why do we need so many chemical similarity search methods?","volume":"7","author":"Sheridan","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.nbd.2018.06.013_bb0240","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1059-1311(00)90467-9","article-title":"Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood","volume":"10","author":"Sigler","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.nbd.2018.06.013_bb0245","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/hmg\/ddq459","article-title":"A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds","volume":"20","author":"Sleigh","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.06.013_bb0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-2003-5404","article-title":"Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761","volume":"5","author":"Smith","year":"2003","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2018.06.013_bb0255","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/brain\/aww101","article-title":"The unfolded protein response: mechanisms and therapy of neurodegeneration","volume":"139","author":"Smith","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.06.013_bb0260","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.06.013_bb0265","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.24.3.250","article-title":"Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy","volume":"24","author":"Strong","year":"1974","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.06.013_bb0270","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.neurobiolaging.2013.03.014","article-title":"Evaluation of longevity enhancing compounds against transactive response DNA-binding protein-43 neuronal toxicity","volume":"34","author":"Tauffenberger","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2018.06.013_bb0275","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1542\/peds.87.2.186","article-title":"Methsuximide for intractable childhood seizures","volume":"87","author":"Tennison","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.nbd.2018.06.013_bb0280","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrd2410","article-title":"Target deconvolution strategies in drug discovery","volume":"6","author":"Terstappen","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2018.06.013_bb0285","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M115.652586","article-title":"Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in amyloid-\u03b2 toxin induced Alzheimer's rat model via PI3K\/Akt\/Wnt\/\u03b2-catenin pathway","volume":"290","author":"Tiwari","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2018.06.013_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000504","article-title":"Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans","volume":"2","author":"Voisine","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.06.013_bb0295","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.013_bb0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.31.6.741","article-title":"Methsuximide for refractory complex partial seizures","volume":"31","author":"Wilder","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.06.013_bb0305","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/hmg\/ddh209","article-title":"Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans","volume":"13","author":"Williams","year":"2004","journal-title":"Hum. Mol. Genet."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611830192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611830192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T08:05:44Z","timestamp":1751702744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611830192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":61,"alternative-id":["S096999611830192X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.06.013","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Methyl-\u03b1-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}